Previously, decreased H3K4me3 by AKT inhibitor MK2206 in PIK3CA-mutated TNBC cells was shown to be associated with the suppressed expression of aurora kinase B (AURKB), proliferating cell nuclear antigen (PCNA) and other genes that are critical to breast cancer survival 30. Here, AURKB is linked to breast carcinoma.